Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00504218 : Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
AgesMin: 2 Years Max: 24 Years

- Age greater than or equal to 2 years.

- History of diagnosis of childhood malignancy or HSCT and completion of therapy prior
to entering the study. In order to be eligible for the study, patients must have been
diagnosed with cancer prior to the age of 18. Eligible patients must be free of
their underlying malignancy for at least one year prior to entering the study, as
confirmed by records from the referring oncologist.

- We will request permission to administer the Child Health Questionnaires (PF 50 and
CF87) to all patients who are enrolled in this protocol. Patients who do not speak
and read English will be excluded from the questionnaire. This instrument has been
validated for use in children ages five and older. Children 10 years and older will
complete the child version. The Child Health Questionnaire (CHQ) has been normed in a
representative sample in the US, and is being used in large population studies in
Australia, Ireland, and the UK. Additionally, it has been rigorously translated into
a number of languages using international guidelines including American-Spanish,
Canadian French, Dutch, Finnish, French, German, Italian, Greek, Honduran- Spanish,
Mexican-Spanish, Norwegian, Portuguese, and Swedish. For this study will purchase the
CHQ in American- Spanish in order to include Spanish-speaking subjects in this part
of the study. The costs to purchase the CHQ in numerous languages would be
prohibitive for this pilot study. However, if a significant number of subjects in a
specific language are recruited, we will consider the purchase of the CHQ for that
group of subjects.


-None besides not meeting the inclusion.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557